Triple negative breast cancer (TNBC) is a complex and malignant breast cancer subtype that
lacks expression of the estrogen receptor (ER), progesterone receptor (PR) and human …

Triple-negative breast cancers (TNBCs) are a group of aggressive breast cancers with a
greater incidence of relapse, stage-for-stage, than ER/PR-positive and HER2-positive breast …

Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not
express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth …

Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer (BC)
with a poor prognosis. Current treatment options are limited to surgery, adjuvant …

Triple-negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors
that by definition lack estrogen and progesterone receptors and amplification of the HER2 …

Significant research has been conducted to better understand the extensive, heterogeneous
molecular features of triple-negative breast cancer (TNBC). We reviewed published TNBC …

Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is
defined by negative estrogen receptor (ER), progesterone receptor (PR) and human …

Background Triple-negative breast cancer (TNBC) is a heterogeneous entity that
encompasses several subtypes with distinct molecular characteristics. The patients with …

Breast cancer is the most prevalent cancer in women worldwide. Triple‑negative breast
cancer (TNBC) is characterized by the lack of expression of estrogen receptor, progesterone …

Triple negative breast cancer (TNBC) is a subtype of breast cancer (BC) with a
heterogeneous nature that stains negatively for estrogen receptor (ER), progesterone …